Financial results to be released after
market close; Conference call to be conducted at 5:00 pm ET
PHOENIX, Nov. 5, 2024
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report
financial results for its third quarter 2024, ended September 30, 2024, after the market close on
Tuesday, November 12, 2024. The
Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results.
Third Quarter 2024 Conference Call Details
Date and Time: Tuesday, November
12, 2024, at 5:00 pm ET
Call-in Information: Interested parties can access the
conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access
the conference call via a live webcast, which is available in the
Investor Relations section of the Company's website at
https://app.webinar.net/B3g7axqE1nv or
http://senestech.investorroom.com/.
Replay: A teleconference replay of the call will be
available for seven days at (877) 344-7529 or (412) 317-0088,
replay access code 2809220. A webcast replay will be available in
the Investor Relations section of the Company's website at
http://senestech.investorroom.com/ for 90 days.
About SenesTech
We are committed to improving
the health of the world by humanely managing animal pest
populations through our expertise in fertility control. We
invented ContraPest, the only U.S. EPA-registered
contraceptive for male and female rats, as well as Evolve and
Evolve Mouse, EPA-designated minimum risk contraceptives for
rodents, reflecting our mission to provide products that are
proactive, safe and sustainable. ContraPest and Evolve
fit seamlessly into all integrated pest management programs,
significantly improving the overall goal of effective pest
management. We strive for clean cities, efficient businesses and
happy households – with a product designed to be humane, effective
and sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
This press release contains "forward-looking statements" within
the meaning of federal securities laws, and we intend that such
forward-looking statements be subject to the safe harbor created
thereby. Forward-looking statements may describe future
expectations, plans, results or strategies and are often, but not
always, made through the use of words such as "believe," "may,"
"future," "plan," "will," "should," "expect," "anticipate,"
"eventually," "project," "estimate," "continuing," "intend" and
similar words or phrases. You are cautioned that such
statements are subject to risks, uncertainties and other factors
that could cause actual results to differ materially from those
reflected by such forward-looking statements. Such factors
include, among others, the successful commercialization of our
products; market acceptance of our products; our financial
performance, including our ability to fund operations; our ability
to regain and maintain compliance with Nasdaq's continued listing
requirements; and regulatory approval and regulation of our
products and other factors and risks identified from time to time
in our filings with the Securities and Exchange Commission,
including our Annual Report on Form 10-K for the fiscal year ended
December 31, 2023. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date.
Except as required by law, we do not undertake any obligation to
publicly update any forward-looking statements, whether as a result
of the receipt of new information, the occurrence of future events
or otherwise.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-third-quarter-2024-financial-results-on-tuesday-november-12-2024-302295878.html
SOURCE SenesTech, Inc.